The laboratory filtration market is expected to grow at a decent pace during the forecast period, according to the research report published by P&S Intelligence. The market is mainly driven by the increasing use of laboratory filtration products in the food and beverage industry, introduction of technologically advanced products, increasing research activities in pharmaceutical and biopharmaceutical industries, and surge in the adoption of filtration products in clinical laboratories. The increasing reliance on filtration techniques to obtain purified products is becoming a trend across various industries. In the pharmaceutical sector, the tissue culture media is filtered using several techniques such as membrane filtration to address diseases and manufacture new drugs. Membrane filters are also being used as a means of monitoring in-water microbiology and air pollution. Biomimetic membranes have been developed as a water filtration technology that replicates the process occurring at the cellular level. The laboratory filtration market is being driven by numerous factors; one of these is the increasing research in biopharmaceutical and pharmaceutical industry. Water is required in its purest form for the research and manufacture of pharmaceutical and biopharmaceutical products. To obtain microbe-free water, several filtration techniques are used, such as ultrafiltration, vacuum filtration, and microfiltration, as these provide precise and reliable samples. The market is expected to grow because of the rise in demand for biopharmaceutical and pharmaceutical products. Download sample copy of this report@ https://www.psmarketresearch.com/market-analysis/laboratory-filtration-market/report-sample When segmented by product, the market is divided into filtration assemblies, filtration media, and filtration accessories. Laboratory filtration media was the dominating category during the historical period (2013–2017). This is credited to the fact that this category includes products such as filter papers, membrane filters, and filtration microplates that see heavy usage in research facilities. This is why the laboratory filtration market is expected to grow to $1,438.3 million in this category by 2023, attaining a CAGR of 6.8% during the forecast period. Therefore, the rising demand for pharmaceutical and biopharmaceutical products, which would lead to an even heavier usage of the filtration process in laboratories, is predicted to supplement the growth of the market
0 Comments
9/17/2019 0 Comments Microbial Identification Market Overview, Growth Drivers and Forecast Report 2022The microbial identification market size is projected to reach $1.4 billion by 2022. The increasing incidence of infectious diseases, increasing healthcare spending, increasing food safety concerns, and technological advancement in microbial identification are driving the growth of the market.
Broadly, the microbial identification market by product is segmented into Consumables, Instruments and Software and Services. The consumables segment accounted for largest share in the global market, and it is expected to retain its position by 2022. In terms of application the microbial identification market includes diagnostic application, food and beverage testing, pharmaceutical application and environmental application. In 2015, the diagnostic segment accounted for the major share and is expected to grow at a CAGR of 6.0% during the period 2016-2022. Request for report sample at: https://www.psmarketresearch.com/market-analysis/microbial-identification-market/report-sample The various end-users of microbial identification market are hospitals, pharmaceutical & biotech companies, food, water, and beverage manufacturers, research laboratories, government environmental agencies, blood banks and others. In 2015, the Hospitals segment accounted for the major share and is expected to grow at a CAGR of 6.4% during the period 2016-2022. The key companies operating in the microbial identification market include Becton, Dickinson and Company, Danaher Corporation, Siemens AG, Shimadzu Corporation, BioMerieux SA, Thermo Fisher Scientific Inc., Qiagen N.V., Midi Inc, Charles River Laboratories Inc., Biolog Inc. and Bruker Corporation. The global cartilage repair market is witnessing considerable growth due to increasing geriatric population, increasing obesity, increasing healthcare expenditure, and growing sports related injuries. Moreover, increase in innovative product launches and growth of medical tourism leading to awareness about the cartilage treatment modalities across the globe is supporting the growth of the market. Based on the treatment modalities, cell-based approaches segment is expected to grow at the fastest rate during the forecast period, due to long term results of this treatment. The rapid growth in emerging economies and technological advancement in cartilage repair and regeneration products is expected to create opportunities for the manufacturers of cartilage repair products across the globe. However, the high cost of these products and lack of reimbursement for these treatments are the key factors hampering the growth of the global market. Geographically, North America has been the largest market for cartilage repair, owing to increasing prevalence of obesity, increasing healthcare expenditure, increased awareness, and easy accessibility to advanced technologies for cartilage repair and regeneration. The U.S. contributed largest revenue to the North American as well as global cartilage repair market. The increasing prevalence of sports injuries and increase in geriatric pool is the key driving factor for the U.S. cartilage repair market. The key players operating in the global cartilage repair market are Zimmer Biomet Holdings, Inc., Johnson & Johnson, Vericel Corporation, Smith & Nephew PLC, Osiris Therapeutics, Inc., RTI Surgical, Conmed Linvatec, B. Braun Melsungen AG, Anika Therapeutics S. R. L. and Arthrex, Inc. |
Lifescience Industry NewsLife science is a diversified industry that encompass Healthcare, Healthcare IT, Medical Devices, Pharmaceuticals, Biotechnology and Analytical & Scientific Instrumentation. The healthcare, biotechnology and pharmaceutical industries have been experiencing a significant spur in demand due to shifting demographics, changing healthcare trends, new diseases, technological advancements and transforming market scenarios. Healthcare IT and Medical Devices industries have been playing a transformative and beneficial role in healthcare through digitization of healthcare data and evolution of innovative technologies.
Business |